NL-OMON34238CompletedPhase 3
An open-label extension study of CACZ885H2357E1 on the treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffective - H2357E2
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- ovartis
- Enrollment
- 1
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Successful completion of preceding study CACZ885H2357E1 or 9 flares during that study.
Exclusion Criteria
- •Pregnancy and lactation.
- •No contraception or insufficiently safe contraception method (women of childbearing potential)
Investigators
Similar Trials
Active, not recruiting
Phase 1
An open-label extension study of CACZ885H2357E1 on the treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffective - H2357E2Treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffectiveMedDRA version: 12.1Level: LLTClassification code 10018627Term: GoutEUCTR2010-020060-38-NLovartis Pharma Services AG
Active, not recruiting
Not Applicable
An open-label extension study of CACZ885H2356E1 on the treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffective - H2356E2Treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffectiveMedDRA version: 12.1Level: LLTClassification code 10018627Term: GoutEUCTR2010-019559-23-SEovartis Pharma Services AG200
Active, not recruiting
Not Applicable
An open-label extension study of CACZ885H2356E1 on the treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffective - H2356E2Treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffectiveMedDRA version: 12.1Level: LLTClassification code 10018627Term: GoutEUCTR2010-019559-23-DEovartis Pharma Services AG200
Active, not recruiting
Not Applicable
/AEUCTR2010-019559-23-LVovartis Pharma Services AG200
Active, not recruiting
Not Applicable
An open-label extension study of CACZ885H2356E1 on the treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffective - H2356E2EUCTR2010-019559-23-LTovartis Pharma Services AG200